Immunology of skin transplantation

被引:56
作者
Richters, CD
Hoekstra, MJ
du Pont, JS
Kreis, RW
Kamperdijk, EWA
机构
[1] EuroSkin Bank, NL-1940 EA Beverwijk, Netherlands
[2] Vrije Univ Amsterdam, Fac Med, Dept Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands
[3] Burns Res Inst, NL-1940 EB Beverwijk, Netherlands
关键词
D O I
10.1016/j.clindermatol.2004.07.022
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Untreated viable allogeneic skin is highly immunogenic. Epidermal Langerhans migrate after transplantation out of the donor skin into the lymph node of the recipient where they can activate T cells capable to mediate rejection. Allogeneic skin is used as a temporary coverage of burn Wounds. often in combination with autologous skin grafts. Several methods to pretreat the allogeneic skin have been used to delay the rejection process. Processing of allogeneic skin in 85% glycerol results in a non-viable skin with a well-preserved structure. Experiments in a full thickness porcine Wound model showed that rejection Of glycerol treated allogeneic skin grafts was up to six days delayed. Viable. untreated allogeneic skin grafts were rejected predominantly by CD8 positive T cells whereas in the glycerol treated grafts the influx of host cells was lower and the majority of the cells were macrophages, The outgrowth of the autologous skin grafts underneath glycerol treated allogeneic skin was three days earlier completed when compared to grafts in combination with untreated allogencic skin, Thus, by processing the allogencic skin into 85% glycerol, the direct route to induce graft rejection is blocked since the Langerhans cells are non-viable. The glycerol-preserved skin grafts are finally rejected via an indirect route mediated by macrophages; this process is less disturbing for the outgrowth Or autologous Cells, (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:338 / 342
页数:5
相关论文
共 27 条
[1]  
ABERER W, 1984, J IMMUNOL, V133, P702
[2]  
ACHAUER BM, 1986, LANCET, V1, P14
[3]  
ALSJBORN BF, 1985, BURNS, V11, P259
[4]   TRANSGENIC MICE EXPRESSING A SOLUBLE FOREIGN H-2 CLASS-I ANTIGEN ARE TOLERANT TO ALLOGENEIC FRAGMENTS PRESENTED BY SELF CLASS-I BUT NOT TO THE WHOLE MEMBRANE-BOUND ALLOANTIGEN [J].
ARNOLD, B ;
MESSERLE, M ;
JATSCH, L ;
KUBLBECK, G ;
KOSZINOWSKI, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1762-1766
[5]   REJECTION, AFTER A SLIGHTLY PROLONGED SURVIVAL-TIME, OF LANGERHANS CELL FREE ALLOGENEIC CULTURED EPIDERMIS USED FOR WOUND COVERAGE IN HUMANS [J].
AUBOCK, J ;
IRSCHICK, E ;
ROMANI, N ;
KOMPATSCHER, P ;
HOPFL, R ;
HEROLD, M ;
SCHULER, G ;
BAUER, M ;
HUBER, C ;
FRITSCH, P .
TRANSPLANTATION, 1988, 45 (04) :730-737
[6]   ROLE OF AFFERENT LYMPHATICS IN REJECTION OF SKIN HOMOGRAFTS [J].
BARKER, CF ;
BILLINGHAM, RE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 128 (01) :197-+
[7]  
Burd Andrew, 2002, Burns, V28 Suppl 1, pS34
[8]   TEMPORARY SKIN TRANSPLANTATION AND IMMUNOSUPPRESSION FOR EXTENSIVE BURNS [J].
BURKE, JF ;
MAY, JW ;
ALBRIGHT, N ;
QUINBY, WC ;
RUSSELL, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (05) :269-271
[9]   Evaluation of donor skin viability: fresh and cryopreserved skin using tetrazolioum salt assay [J].
Castagnoli, C ;
Alotto, D ;
Cambieri, I ;
Casimiri, R ;
Aluffi, M ;
Stella, M ;
Alasia, ST ;
Magliacani, G .
BURNS, 2003, 29 (08) :759-767
[10]   COMPOSITE AUTOLOGOUS-ALLOGENEIC SKIN REPLACEMENT - DEVELOPMENT AND CLINICAL-APPLICATION [J].
CUONO, CB ;
LANGDON, R ;
BIRCHALL, N ;
BARTTELBORT, S ;
MCGUIRE, J .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1987, 80 (04) :626-635